Toward Optimized <sup>89</sup>Zr-Immuno-PET: Side-by-Side Comparison of [<sup>89</sup>Zr]Zr-DFO-, [<sup>89</sup>Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [<sup>89</sup>Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
<sup>89</sup>Zr represents a highly favorable positron emitter for application in immuno-PET (Positron Emission Tomography) imaging. Clinically, the <sup>89</sup>Zr<sup>4+</sup> ion is introduced into antibodies by complexation with desferrioxamine B. However, pro...
Saved in:
Main Authors: | Helen Damerow (Author), Xia Cheng (Author), Valeska von Kiedrowski (Author), Ralf Schirrmacher (Author), Björn Wängler (Author), Gert Fricker (Author), Carmen Wängler (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Response Monitoring with <sup>89</sup>Zr-DFO-Pertuzumab in HER2-Positive and Trastuzumab-Resistant Breast Cancer Models
by: Minwoo Kang, et al.
Published: (2022) -
Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE
by: Asif Noor, et al.
Published: (2024) -
Quantitative Biodistribution and Pharmacokinetics Study of GMP-Grade Exosomes Labeled with <sup>89</sup>Zr Radioisotope in Mice and Rats
by: Hojun Choi, et al.
Published: (2022) -
Simplified <sup>89</sup>Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells
by: Andras Polyak, et al.
Published: (2021) -
Good practices for 89Zr radiopharmaceutical production and quality control
by: Thomas Erik Wuensche, et al.
Published: (2024)